JAMA Medical News

COVID-19 and the Common Cold: Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity; When Physicians Spread Unscientific Information About COVID-19; How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic.

Related Content:

• COVID-19 and the Common Cold—Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity
• When Physicians Spread Unscientific Information About COVID-19
• How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic

Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis; RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths; Preparing Hospitals’ Medical Oxygen Delivery Systems for a Respiratory “Twindemic.”

Related Content:

• Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis
• RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths
• Preparing Hospitals’ Medical Oxygen Delivery Systems for a Respiratory “Twindemic”

Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19; COVID-19 Vaccine Makers Plan for Annual Boosters, but It’s Not Clear They’ll Be Needed; Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.

Related Content:

• Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19
• The Debate Over Whether Repeated COVID-19 Boosters Will Be Needed
• Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19

JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with physician-geneticist Francis S. Collins, MD, PhD, as he steps down as director of the National Institutes of Health (NIH) and returns full-time to his laboratory at the National Human Genome Research Institute. Collins discusses the NIH’s biggest accomplishments and challenges during his historic tenure, shares what he will and won’t miss about the job, and much more.

Related Content:

After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity, Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis, Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents.

Related Article(s):

• The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity
• Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis
• Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents

JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with Manesh Patel, MD, about the latest trials and topics from the American Heart Association’s Scientific Sessions meeting. Patel is chief of the division of cardiology at Duke University School of Medicine and this year’s Scientific Sessions conference chair.

Related Content:

• Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
• Highlights From the American Heart Association’s Scientific Sessions—ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, Aspirin and Dementia, and More

Authors have declared conflicts of interest related to the article discussed in this podcast. Visit the article on jama.com for the complete disclosure.

COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound

Related Content:

• COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
• COVID-19 Testing Moves Out of the Clinic and Into the Home
• The Lingua Franca of Addiction—Stigmatizing Words That Wound

The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford Foundation in New York City, discusses the challenges skilled nursing facilities face and shares her vision for nursing homes that better serve residents and support the workforce.

Related Content:

• COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
• Socially Assistive Robots Help Patients Make Behavioral Changes

After Mildest Flu Season Ever, Influenza Experts Wonder What Comes Next; Why Farmworkers Need More Than New Laws for Protection From Heat-Related Illness; COVID-19 Sets Back Efforts to See the Person in the ICU Patient

Related Content:

• After Mildest Flu Season Ever, Influenza Experts Wonder What Comes Next
• Why Farmworkers Need More Than New Laws for Protection From Heat-Related Illness
• How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals

Many patients experience neurocognitive deficits, PTSD, and generalized weakness and disability following an intensive care unit (ICU) stay. JAMA Medical News Senior Writer Rita Rubin talks with E. Wesley Ely, MD, MPH, a professor of medicine at Vanderbilt University School of Medicine, about ICU aftereffects, post-acute COVID-19 syndrome, and how the coronavirus pandemic, particularly hospitals’ restrictions on visitors, impeded progress made since the 1990s in caring for the critically ill.

Related Content:

How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals